MongoDB, Inc. (MDB) is a New York-based database software company whose flagship Atlas cloud service and Enterprise Advanced offering serve more than 70,000 organizations worldwide. The stock traded at $297.81 shortly after 11 a.m. in New York, down $19.11, or 6.03%, from Monday's close of $316.92. Shares opened near $326 and weakened steadily, touching roughly $295 — a loss of nearly 7% at the session low. The move is clearly to the downside and comes with no company-issued news release. The most concrete verified development is a regulatory filing showing a prominent activist investor liquidated its stake, layered on top of insider selling and a stock already trading below every major moving average.
The clearest identifiable catalyst is the quarterly holdings disclosure revealing that ValueAct Capital sold out of MongoDB entirely during the three months ended Sept. 30, alongside new positions in Agilent and Motorola Solutions. ValueAct had already cut its position by 84% in the prior quarter, to about 165,700 shares, so the exit completes a retreat that began earlier in the year. Because 13F filings are backward-looking, the news says little about current fundamentals — but it removes a well-known supportive holder from the register and signals that at least one large, research-intensive fund chose to redeploy capital elsewhere. In a name with a beta near 2.1 and limited near-term conviction, that kind of supply signal tends to amplify selling.
Separate insider filings showed director Dwight Merriman selling 10,000 shares worth roughly $3.49 million, with smaller sales by another director. Insider activity at MongoDB has been persistently one-sided over the past year, and each disclosure reinforces the impression that those closest to the business are trimming exposure. Investors are also still digesting class-action litigation examining potential fiduciary breaches by management, an unresolved item that has pressured sentiment through the autumn and has not been dismissed or settled.
MongoDB reports fiscal third-quarter results after the close on Dec. 1. The prior quarter showed revenue of $771.8 million, up 30.5% year over year, and non-GAAP earnings of $0.50 per share — operationally solid numbers. But the stock's reaction to that report was negative, and with a forward valuation multiple in the hundreds of times earnings, expectations around Atlas consumption growth are unforgiving. De-risking into a binary event is a plausible contributor to the current weakness.
Turnover early in the session was tracking near the stock's normal pace of roughly 1.2 million shares a day rather than showing a capitulation spike, which argues against a single forced seller. Technicals are decisively bearish: the shares are below the 50-day average near $364 and the 200-day near $334, with the 14-day relative strength index in the high 30s. The stock has lost about 31% in three months and roughly 29% year to date, and it has repeatedly swung by 6% or more — a pattern of high-beta, momentum-driven trading rather than an isolated break.
The scale runs from 0, meaning no meaningful news and a normal move, to 100, meaning transformative news and an extreme, rare move. This event scores 21 out of 100. The verified news is genuine but second-tier: a full institutional exit already largely telegraphed, routine insider sales, and pending litigation — material to sentiment, not to the business model. The price behavior was likewise unremarkable by this stock's standards. The 6.03% decline was about 1.7 times the average absolute daily move of roughly 3.5%, and moves of equal or greater size occurred 12 times in the prior 69 sessions. Weak news and a familiar-sized swing combine into a low score.
Attention now shifts to the Dec. 1 fiscal third-quarter report, where investors will focus on Atlas consumption growth, net customer additions, and any change to full-year guidance. Analyst sentiment remains broadly constructive, with a consensus buy rating and a wide spread of targets, but several firms have already trimmed numbers this year. Sector developments matter too: competition from hyperscaler database services and AI-native vector databases remains the central structural debate. Key risks include a guidance reset, further leadership turnover in the sales organization, adverse litigation developments, and continued multiple compression if software valuations stay under pressure.
Tickeron's Trending AI Robots page showcases a curated selection drawn from hundreds of AI trading bots that cover thousands of tickers. Because bot performance shifts with market conditions, only the strongest performers in the current environment make this list. Strategies differ widely by approach, timeframe, performance metrics, and the specific symbols they trade, letting users compare methodologies side by side. For readers tracking volatile software names like this one, reviewing the Trending AI Robots lineup is a practical next step.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
The Aroon Indicator for MDB entered a downward trend on November 17, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 204 similar instances where the Aroon Indicator formed such a pattern. In 178 of the 204 cases the stock moved lower. This puts the odds of a downward move at 87%.
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MDB as a result. In 63 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 72%.
The Moving Average Convergence Divergence Histogram (MACD) for MDB turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 33 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.
MDB moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +2.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where MDB advanced for three days, in 236 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
MDB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 72 (best 1 - 100 worst), indicating slightly worse than average price growth. MDB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.457) is normal, around the industry mean (16.188). P/E Ratio (434.486) is within average values for comparable stocks, (45.064). Projected Growth (PEG Ratio) (1.654) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.427) among similar stocks. P/S Ratio (11.025) is also within normal values, averaging (103.301).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of MongoDB database
Industry ComputerCommunications